New revolutionary heart failure drug trial by Dr Flett
Andrew Flett has secured charitable funding to conduct a study looking at the effects of Entresto, a new revolutionary heart failure drug, on the heart using an MRI scan. The research led by Dr Flett will help our understanding of this condition and how to treat it. See the attached press release for more details.
Related Articles
Explore our latest insights and guidance on heart health, cardiac conditions and specialist assessments. Our articles are written by experienced consultant cardiologists and are designed to help patients, referrers and families better understand key topics in cardiovascular care, as well as the services we provide at Wessex Cardiology.
Get in touch
Please note that with increased demand, and long NHS waits, our services and office are under more demand than ever. As a result our staff are exceptionally busy and often working under great pressure.